Repertoire analysis: a key to super-personalized medicine

Repertoire Genesis is revealing new possibilities for personalized diagnosis and treatment with its technology platform for unbiased next-generation T and B cell receptor repertoire analysis. To download the full article, please sign in.

Like Comment
Page of
Go to the profile of Repertoire Genesis

Repertoire Genesis

We have a world's best unbiased gene analysis method of T cell receptor (TCR) and B cell receptor (BCR). Our technology makes it possible to evaluate treatment effects of cancer immune cell therapy, bone marrow transplantation, or immune check point inhibitors. Our platform technology can also be used for development of promising advanced medical technologies such as TCR gene therapy, CAR-T therapy, and antibody drug development.

No comments yet.